Cortactin (CTTN) (Middle Region) Peptid
CTTN
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle Cortactin (CTTN) Produkte
- Cortactin (CTTN)
- Protein Region
- Middle Region
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Sequenz
- YSSGFGGKYG VQADRVDKSA VGFDYQGKTE KHESQRDYSK GFGGKYGIDK
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti- CTTN Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- Cortactin (CTTN)
- Hintergrund
-
This gene is overexpressed in breast cancer and squamous cell carcinomas of the head and neck. The encoded protein is localized in the cytoplasm and in areas of the cell-substratum contacts. This gene has two roles: (1) regulating the interactions between components of adherens-type junctions and (2) organizing the cytoskeleton and cell adhesion structures of epithelia and carcinoma cells. During apoptosis, the encoded protein is degraded in a caspase-dependent manner. The aberrant regulation of this gene contributes to tumor cell invasion and metastasis. Three splice variants that encode different isoforms have been identified for this gene.
Alias Symbols: EMS1
Protein Size: 634 - Gen-ID
- 2017
- NCBI Accession
- NM_001184740, NP_001171669
-
Sie sind hier:
